Role of the hyaluronidase in GBS Virulence

NIH RePORTER · NIH · R01 · $904,350 · view on reporter.nih.gov ↗

Abstract

PROJECT SUMMARY Morbidity and mortality of preterm and newborn infants remain significant public health concerns. Streptococcus agalactiae or Group B Streptococcus (GBS) are a leading cause of bacterial infection associated preterm births, stillbirths and early onset sepsis. We recently showed that increased expression of the hyaluronidase can be associated with GBS invasive disease and induces fetal demise in pregnant mice. The objective of this proposal is to understand how the GBS hyaluronidase subverts the function of multiple host innate immune cells to induce fetal injury and systemic infection. Aim 1 will define mechanisms by which the GBS hyaluronidase subverts immune cell function and immune cell recruitment. Aim 2 will establish how expression of the GBS hyaluronidase promotes microbial invasion of the amniotic cavity and fetal injury in the pregnant nonhuman primate model that closely emulates human pregnancy. These studies will provide novel insight into mechanisms of immune evasion during GBS infections. These results are essential and invaluable for development of novel therapeutic approaches to reduce the risk of GBS infection associated fetal injury, stillbirth, preterm births and neonatal infections.

Key facts

NIH application ID
10149916
Project number
5R01AI133976-05
Recipient
SEATTLE CHILDREN'S HOSPITAL
Principal Investigator
Kristina M. Adams Waldorf
Activity code
R01
Funding institute
NIH
Fiscal year
2021
Award amount
$904,350
Award type
5
Project period
2017-06-20 → 2023-11-30